SCHOTT Pharma AG & Co. KGaA Total Liabilities

Latest as of September 2024: €650.00 Million EUR ≈ $759.92 Million USD

SCHOTT Pharma AG & Co. KGaA total liabilities. Based on the latest financial reports, SCHOTT Pharma AG & Co. KGaA (1SXP) has total liabilities worth €650.00 Million EUR (≈ $759.92 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SCHOTT Pharma AG & Co. KGaA liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of SCHOTT Pharma AG & Co. KGaA (2020–2024)

Total liabilities of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. This chart illustrates how SCHOTT Pharma AG & Co. KGaA's total liabilities have evolved over time, based on quarterly financial data.

SCHOTT Pharma AG & Co. KGaA Competitors by Total Liabilities

The table below lists competitors of SCHOTT Pharma AG & Co. KGaA ranked by their total liabilities.

Company	Country	Total Liabilities
Chung-Hsin Electric & Machinery Mfg Corp TW:1513	Taiwan	NT$26.88 Billion
Zhejiang Provincial New Energy Investment Group Co Ltd SHG:600032	China	CN¥40.16 Billion
Liberty Energy Inc. NYSE:LBRT	USA	$2.52 Billion
Henan Huanghe Whirlwind Co Ltd SHG:600172	China	CN¥6.74 Billion
CECEP Solar Energy Co Ltd SHE:000591	China	CN¥28.42 Billion
Charoen Pokphand Indonesia TBK PT JK:CPIN	Indonesia	Rp11.81 Trillion
Coface SA PA:COFA	France	€6.30 Billion
Top Choice Medical Investment Co Inc SHG:600763	China	CN¥1.45 Billion

Liability Composition Analysis (2020–2024)

This chart breaks down SCHOTT Pharma AG & Co. KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 1SXP asset base.

Liquidity & Leverage Metrics

SCHOTT Pharma AG & Co. KGaA Total Liabilities Ratios Explained

SCHOTT Pharma AG & Co. KGaA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.82	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.45	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SCHOTT Pharma AG & Co. KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SCHOTT Pharma AG & Co. KGaA (2020–2024)

The table below shows the annual total liabilities of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024.

Year	Total Liabilities	Change
2024-06-30	€650.00 Million ≈ $759.92 Million	+20.45%
2023-06-30	€539.65 Million ≈ $630.91 Million	+10.71%
2022-06-30	€487.46 Million ≈ $569.89 Million	+52.10%
2021-06-30	€320.48 Million ≈ $374.67 Million	+14.31%
2020-06-30	€280.36 Million ≈ $327.77 Million	--

About SCHOTT Pharma AG & Co. KGaA

XETRA:1SXP Germany Medical Instruments & Supplies

Market Cap

$4.41 Billion

€3.77 Billion EUR

Market Cap Rank

#5395 Global

#871 in Germany

Share Price

€25.05

Change (1 day)

+0.20%

52-Week Range

€12.96 - €26.00

All Time High

€41.20